Lars Palmqvist

Head of department / Professor

University of Gothenburg

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Lars Palmqvist is the Head of Department at the University of Gothenburg, Sweden. His research focuses on precision medicine in acute leukemias, with recent publications exploring whole-genome sequencing, stem cell models, and DNA methylation signatures. His work emphasizes the importance of molecular mechanisms and treatment responses in pediatric acute myeloid leukemia.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Jonas Abrahamsson

University of Gothenburg

SWEDEN

View details

Gunnel Nordmark

Associate Professor, adjunct lecturer

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lars Palmqvist

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Implementing precision medicine in a regionally organized healthcare system in Sweden

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages

Fusion transcript analysis reveals slower response kinetics than multiparameter flow cytometry in childhood acute myeloid leukaemia

Mnx1 Induces Leukemia Transformation Through Altering Histone Methylation in a Model of Pediatric Acute Myeloid Leukemia with t(7;12)(q36;p13)

Reduced mitochondrial transcription sensitizes acute myeloid leukemia cells to BCL-2 inhibition

DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML)

DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML)

ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients

MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells

Collaborators (2)

Jonas Abrahamsson

Gunnel Nordmark

Make your next move.